STROBE MR

STROBE-MR: Transparent reporting of Mendelian randomization studies

STROBE-MR stands for “Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomization”. Inspired by the original STROBE checklist, the STROBE-MR guidelines were developed to assist researchers in reporting their Mendelian randomization studies clearly and transparently. These guidelines consist of the STROBE-MR Statement with a checklist, which contains items recommended to address in reports of Mendelian randomization studies, and the Explanation and Elaboration document, which explains meaning and rationale of the checklist items coupled with examples of transparent reporting.

Members of the STROBE-MR Initiative:

George Davey Smith
MRC Integrative Epidemiology Unit, University of Bristol (UK)

Neil M Davies
MRC Integrative Epidemiology Unit and Population Health Sciences, University of Bristol (UK)
K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology (Norway)

Niki Dimou
Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon (France)

Matthias Egger
Institute for Social and Preventive Medicine, University of Bern (Switzerland)
Population Health Sciences, Bristol Medical School, University of Bristol (UK)
Centre for Infectious Disease Epidemiology and Research, University of Cape Town (South Africa)

Valentina Gallo
Campus Fryslân, University of Groningen, Leeuwarden (Netherlands)

Robert M Golub
Deputy Editor, JAMA, Chicago, IL (USA)
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (USA)

Julian PT Higgins
MRC Integrative Epidemiology Unit, University of Bristol (UK)
NIHR Bristol Biomedical Research Centre, Bristol (UK)

Claudia Langenberg
MRC Epidemiology Unit, University of Cambridge (UK)
Berlin Institute of Health at Charité – Universitätsmedizin Berlin (Germany)

Elizabeth W Loder
Division of Headache, Department of Neurology, Brigham and Women’s Hospital, Boston, MS (USA)
Harvard Medical School, Boston, MS (USA)

J Brent Richards
Departments of Medicine, Human Genetics, Epidemiology & Biostatistics, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal (Canada)
Department of Twin Research and Genetic Epidemiology, King’s College London, University of London (UK)

Rebecca C Richmond
MRC Integrative Epidemiology Unit and Population Health Sciences, University of Bristol (UK)

Veronika W Skrivankova
Institute for Social and Preventive Medicine, University of Bern (Switzerland)

Sonja A Swanson
Department of Epidemiology, Erasmus MC, Rotterdam (Netherlands)

Nicholas J Timpson
MRC Integrative Epidemiology Unit and Population Health Sciences, University of Bristol (UK)

Anne Tybjaerg-Hansen
Rigshospitalet, Copenhagen University Hospital, Copenhagen (Denmark)

Tyler J VanderWeele
Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MS (USA)

Benjamin AR Woolf
MRC Integrative Epidemiology Unit and Department of Psychological Science, University of Bristol (UK)

James Yarmolinsky
MRC Integrative Epidemiology Unit and Population Health Sciences, University of Bristol (UK)